QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer

NCT00626106 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast Tumors
Metastatic Cancer

Interventions

DRUG: AMG 479
DRUG: Placebo

Sponsor

NantCell, Inc.